HCPLive

Epilepsy 
The MD Magazine Epilepsy condition center provides clinical news and articles, information about upcoming conferences and meetings, updated clinical trial listings, and other resources.

Latest Headlines

Pregabalin May be Linked to Birth Defects, But to What Extent?
Researchers caution that Pregabalin, an agent approved by the FDA to treat epilepsy, fibromyalgia, and neuropathic pain, may be associated with an increased risk of major birth defects after first trimester exposure, though results are inconclusive.
Pain medications can often cause side effects such as dizziness and sleepiness; but little do pregnant women know that they could be at risk for birth defects when taking pregabalin.
French researchers examined several factors that could contribute to an association between antiepileptic drug use and risk of suicide attempt.
Men diagnosed with multiple sclerosis often have higher blood pressure than women, in addition to higher levels of diabetes, epilepsy, depression, and anxiety.
Patients with epilepsy will soon have another option to control seizures with the approval of a new formulation of perampanel (Fycompa), developed by Eisai Inc.
As more is learned about epilepsy and new treatment methods are introduced to the market there is reason to be optimistic for patients while doctors work to provide the best care possible on an individual basis.
Previous literature has shown a potential challenge for women with epilepsy becoming pregnant a recent study showed that may not be the case after all.
Even if patients could benefit from treatment specialized epilepsy centers they may not know about the care they could receive for a variety of reasons.
Many patients diagnosed with epilepsy need specialized treatments to help manage their symptoms. While people may associate epilepsy centers with surgical procedures they can also provide other benefits as well.

Most Popular

@MDMagazine

$vacMongoViewPlus$ $vAR$